Balyasny Asset Management
DMTK

Balyasny Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Balyasny Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,279
Closed -$74K – 3364
2022
Q2 		$74K Buy
+13,279
New +$109K ﹤0.01% 2318
2021
Q3 		– Sell
-6,679
Closed -$278K – 2531
2021
Q2 		$278K Buy
+6,679
New +$274K ﹤0.01% 1665

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Balyasny Asset Management's DMTK Position: Q3 2022 in Review

Balyasny Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 13,279 shares — an estimated $74K sold.

Balyasny Asset Management first reported a position in DMTK in Q2 2021 and held it in 2 quarters. The position peaked at $278K in Q2 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • Balyasny Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 13,279 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $74K.
  • Balyasny Asset Management first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Balyasny Asset Management's DermTech, Inc. Common Stock position peaked at $278K in Q2 2021.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.